AUS
NZ
UK
CA
USA
IND
Highlights
THG PLC (THG) rejects an acquisition bid for its MyProtein brand from Selkirk Group PLC.
Selkirk's £600 million offer was seen as undervaluing MyProtein, according to THG.
Market response to THG's decision signals confidence in the company's strategy and growth plans.
The health and wellness sector has seen a surge in demand, driven by growing consumer interest in fitness and nutrition. Within this space, THG PLC (LSE:THG) stands out with its MyProtein brand, a major player in the protein supplements market. The company's prominence has attracted attention from various investment groups, eager to capitalize on the ongoing industry expansion.
THG Rejects Acquisition Bid
Recently, THG PLC rejected an acquisition offer for its MyProtein business from Selkirk Group PLC (AIM:SELK). The proposal, valued at approximately £600 million, included a mix of cash and shares. THG described the offer as "wholly unsolicited, largely unfunded, highly conditional, and non-binding." The bid largely consisted of shares in Selkirk, a newly established acquisition vehicle that had only been listed a few months earlier.
The Parties Behind the Bid
Selkirk Group's bid for MyProtein was backed by Kelso Group Holdings PLC (LSE:KLSO), a significant shareholder of THG. Additionally, Selkirk's management team included individuals with close ties to THG, such as former chairman Iain McDonald and former chairman Angus Monro. Despite these connections, THG's management believed that the proposed bid did not accurately reflect the value of MyProtein.
Valuation Discrepancies
The valuation provided by Selkirk for MyProtein was estimated to be between £400 million and £600 million, based on a cash-free, debt-free model. In contrast, Peel Hunt, a broker for THG, assessed the value of THG Nutrition, which includes MyProtein, at approximately £775 million. This difference in valuations highlights the belief within THG that the offer did not align with the brand’s true market value or its growth trajectory. Additional concerns about the complexities of executing the offer and the associated risks were also factors in the company's decision to decline the bid.
THG's Strategic Priorities
Amid the acquisition interest, THG PLC remains focused on reducing its debt and enhancing its growth and cash generation strategies. Since spinning off its Ingenuity division, the company has secured long-term banking facilities aimed at improving its financial position. This approach underscores THG's commitment to driving the growth of its core brands, including MyProtein, and strengthening its operational efficiency.
Market Reaction and Investor Confidence
Following THG's rejection of the bid, the company's share price rose by a notable margin, reflecting investor confidence in its management and strategic direction. The increase in share price signals that the market is supportive of THG’s decision to prioritize organic growth and operational excellence over external acquisitions, reinforcing the company’s potential for continued success in the competitive health and wellness sector.
